Consolidated Statements of Cash Flows - USD ($)	9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016
Cash flows from operating activities
Net loss	$ (9,980,370)	$ (4,564,423)
Adjustments to reconcile net loss to net cash used in operating activities:
Non-cash interest expense	242,982	0
Share-based compensation	136,617	39,031
Depreciation	2,711	2,627
Loss on disposal of asset	967	0
Write-off of deferred financing costs	1,901	69,896
Changes in:
Prepaid expenses	(291,703)	(36,902)
Accounts payable	156,029	(60,803)
Accrued expenses	(157,890)	(23,591)
Net cash used in operating activities	(9,888,756)	(4,574,165)
Cash flows from investing activities
Cash acquired in merger, net of payment in lieu of fractional shares	1,030,123	0
Purchase of property and equipment	(2,523)	(1,582)
Net cash provided by (used in) investing activities	1,027,600	(1,582)
Cash flows from financing activities
Proceeds from issuance of common stock	10,000,000	0
Proceeds from issues of Preferred Series B, net	0	7,994,834
Deferred financing costs	(68,530)	0
Proceeds from convertible notes payable	5,500,000	0
Net cash provided/(used) in financing activities	15,431,470	7,994,834
Net increase in cash and cash equivalents	6,570,314	3,419,087
Cash and cash equivalents at beginning of period	1,834,018	798,545
Cash and cash equivalents at end of period	8,404,332	4,217,632
Supplemental non-cash financing transactions:
Accretion of issuance costs on Series A Convertible Redeemable Preferred stock	51,943	11,130
Accretion of issuance costs on Series B Convertible Redeemable Preferred stock	127,780	0
Conversion of Series A Convertible Redeemable Preferred stock to common stock	4,166,164	0
Conversion of Series B Convertible Redeemable Preferred stock to common stock	8,149,995	0
Conversion of convertible notes payable and accrued interest to common stock	5,674,452	0
Issuance of common stock in Merger (Note 1)	$ 6,978,916	$ 0